Cholesterol at 415: between skepticism and triglycerides
A patient refuses to take statins with a total cholesterol of 415 mg/dL. For many, it is the last straw in the debate over the lipid theory. But what seems like an anecdotal case reveals a deep rift: total cholesterol is no longer the only king, and atherogenic ratios are starting to win the argument.
The dictatorship of total cholesterol
For decades, total cholesterol has been the star marker. However, more and more analyses point out that what matters is not the absolute amount, but the ratio between its fractions. The Castelli index — the ratio of total cholesterol to HDL — should be below 5, and the triglyceride-to-HDL ratio below 2. In the case cited, with a total of 415, if HDL is low, the risk skyrockets; if it is high, the profile may be less alarming. One participant claimed to have a total of 500 with triglycerides of 70 and HDL of 77, giving a total/HDL ratio of 6.49 and a TG/HDL of 0.9, within margins considered acceptable by some experts.
The role of triglycerides and diet
Triglycerides have become the new Achilles' heel. Levels above 150 mg/dL are associated with insulin resistance and higher cardiovascular risk. The recurring advice is to cut carbohydrates and sugars and increase the intake of meat and healthy fats. Niacin (vitamin B3) is mentioned as an alternative to raise HDL and lower triglycerides, although it causes flushing. Red yeast rice is also cited, a supplement containing monacolin K, similar to statins but natural.
The shadow of the pharmaceutical industry
Skepticism toward statins is palpable. They are branded as "Farmafia poisons," and it is claimed that cholesterol thresholds have been artificially lowered to medicalize the population. The anecdote of a friend with cholesterol of 250 who started statins and ended up diabetic with arrhythmias reinforces this distrust. However, clinical evidence shows that statins reduce cardiovascular events in high-risk patients, even though their side effects are real.
New markers: C-reactive protein
A recent article from the American College of Cardiology, picked up by Infobae, suggests that C-reactive protein (CRP) could be a more powerful predictor than cholesterol. Chronic inflammation, rather than lipid deposits, may be behind atherosclerosis. This fits with the view of those who argue that cholesterol becomes oxidized and stops being functional, and that antioxidants are the key.
Unanswered questions
What no data has managed to clarify is why, with similar lipid profiles, some patients suffer heart attacks and others do not. Genetics, lifestyle and inflammation all come into play. Meanwhile, the sensible advice remains to monitor the TG/HDL ratio, avoid excess carbohydrates, and neither demonize cholesterol nor statins without an individualized assessment.
Related discussions in the forum